| __timestamp | Arrowhead Pharmaceuticals, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 7180000000 |
| Thursday, January 1, 2015 | 57410147 | 6704000000 |
| Friday, January 1, 2016 | 41454452 | 7194000000 |
| Sunday, January 1, 2017 | 31690298 | 9982000000 |
| Monday, January 1, 2018 | 52968505 | 9752000000 |
| Tuesday, January 1, 2019 | 81048686 | 9872000000 |
| Wednesday, January 1, 2020 | 128874979 | 13397000000 |
| Friday, January 1, 2021 | 206342000 | 12245000000 |
| Saturday, January 1, 2022 | 297307000 | 13548000000 |
| Sunday, January 1, 2023 | 353188000 | 30531000000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at an impressive $30.5 billion in 2023. This reflects Merck's robust pipeline and strategic focus on groundbreaking therapies. Meanwhile, Arrowhead Pharmaceuticals, a smaller player, increased its R&D spending by more than 1,400%, reaching $353 million in 2023. This growth underscores Arrowhead's aggressive pursuit of novel RNAi-based treatments. Notably, data for 2024 is incomplete, highlighting the dynamic nature of R&D investments. As these companies continue to innovate, their R&D strategies will shape the future of healthcare.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.